Kenvue Inc., the consumer products spinoff from Johnson & Johnson JNJ, +1.00%, has grown the roster of banks underwriting its initial public offering beyond the two original leads . Goldman Sachs ...
Tag: Johnson & Johnson
J&J stock rises after 2023 profit view tops analyst outlook
Johnson & Johnson JNJ, -0.25% stock rose 0.9% in premarket trades on Tuesday after the drug company’s profit outlook for 2023 topped analyst estimates. J&J’s fourth-quarter profit fell 25.7% t...
Why stock market investors should wait for the 10-year Treasury to ‘blink’
When a key part of the U.S. bond market starts shrugging off new Federal Reserve interest rate hikes or tough talk on inflation, it’s probably time to buy stocks, according to James Paulsen, the Leuth...
Johnson & Johnson’s got a new CEO and a plan to split the company in two. Here’s what else to expect out of J&J’s earnings
Johnson & Johnson JNJ, -0.31% has long been viewed as a bellwether stock for other health care companies, given its early slot in the earnings calendar and a business model that spans everything f...